Anti-inflammatory IL-10 is very critical for immunosuppression in CD pathogenesis but therapeutic efforts to enhance its action have failed so far because of systemic toxicity of IL-10 therapies and reduced delivery of IL-10 to the intestinal tissues [126]. This evidence concerns the gene IL10 and Cowden disease.